2017-11-10T07:28:19-06:00 2016-12-31 520982413 GROSS MENDELSOHN & ASSOCIATES PA 36 SOUTH CHARLES ST 18TH FLOOR BALTIMORE MD 21201 990 2016-01-01 954132414 CURESEARCH FOR CHILDREN'S CANCER CURE 2402352200 4600 EAST WEST HIGHWAY NO 600 BETHESDA MD 20814 LAURA THRALL CEO/PRESIDENT 2402352200 2017-11-10 1 JAMES E CRISP P00025401 4106855512 2017-11-10 64.132.215.242 2017-11-10 08:28:12 ES P 6B51B61F0EFF2C2FF8E13CB29D569DDD1D54D3A3 7ED660B1DA5B7572EB4EFB1F9341951127F9693C 2016 2017-02-10 21:41:12Z LAURA THRALL 4600 EAST WEST HIGHWAY NO 600 BETHESDA MD 20814 7273699 0 X WWW.CURESEARCH.ORG X 1987 CA CURESEARCH FUNDS AND SUPPORTS CHIDLREN'S CANCER RESEARCH AND PROVIDES EDUCATION AND RESOURCES TO ALL THOSE AFFECTED BY CHILDREN'S CANCER. 15 15 43 1208 0 0 3341030 2598912 0 0 218793 230809 2804884 2458140 6364707 5287861 2231363 2477612 0 0 2872213 2935510 0 0 1663052 1385996 1141129 6489572 6554251 -124865 -1266390 7210528 6030880 489394 560162 6721134 5470718 X CURESEARCH'S MISSION IS TO FUND AND SUPPORT TARGETED AND INNOVATIVE CANCER RESEARCH WITH MEASURABLE RESULTS, AND TO BE THE AUTHORITATIVE SOURCE OF INFORMATION AND RESOURCES FOR ALL THOSE AFFECTED BY CHILDREN'S CANCER.(SEE SCHEDULE O FOR CONTINUATION)CURESEARCH SUPPORTS CHILDHOOD CANCER RESEARCH AT ALL STAGES ALONG THE RESEARCH CONTINUUM, FROM FELLOWSHIPS THAT ACCELERATE THE CAREERS OF YOUNG RESEARCHERS TO MULTI-MILLION DOLLAR GRANTS THAT SUPPORT RESEARCH TEAMS DEVELOPING POTENTIAL NEW TREATMENTS, TO CLINICAL TRIAL AWARDS THAT ENABLE HOSPITALS TO ENROLL CHILDREN BEING TREATED TODAY. IT PROVIDES EDUCATIONAL RESOURCES TO PARENTS AND CAREGIVERS, INCLUDING PLAIN LANGUAGE INFORMATION ON DIAGNOSIS AND TREATMENT, PROCEDURAL VIDEOS, AND PARENT WEBINARS. CURESEARCH ALSO RAISES FUNDS THROUGH INDIVIDUALS, CORPORATIONS, PRIVATE FOUNDATIONS, AND SPECIAL EVENTS. 0 0 4149437 2477612 CURESEARCH SUPPORTS RESEARCH EFFORTS TO IMPROVE TREATMENTS AND FIND CURES FOR CHILDREN'S CANCER. THROUGH COMPETITIVE GRANT MAKING INITIATIVES, CURESEARCH FUNDS RESEARCH TEAMS ACROSS THE COUNTRY THAT STUDY MORE THAN 12 TYPES OF CHILDREN'S CANCER WITH THE GOAL OF IMPROVING CURRENT TREATMENTS, DEVELOPING NEW THERAPIES, AND UNDERSTANDING THE BIOLOGY OF MORE PEDIATRIC CANCER DISEASE TYPES. CURESEARCH FUNDS RESEARCH AT ALL STAGES OF THE PIPELINE, INCLUDING BASIC SCIENCE, TRANSLATIONAL RESEARCH, CLINICAL TRIAL DEVELOPMENT, AND THE TESTING OF NEW CANCER THERAPIES. THIS RESEARCH IMPACTS OVER 15,700 CHILDREN DIAGNOSED WITH CANCER EACH YEAR WITH THE LONG-TERM GOAL OF DEVELOPING THERAPIES THAT CURE CHILDREN TODAY WITHOUT HARMING THEM TOMORROW. (SEE SCHEDULE O FOR CONTINUATION)CURESEARCH FUNDS CLINICAL TRIALS ACROSS THE COUNTRY. CLINICAL TRIALS ENSURE THAT CHILDREN WITH CANCER GET ACCESS TO THE BEST CURRENT TREATMENTS. THE DATA COLLECTED FROM CLINICAL TRIALS ENABLES RESEARCHERS TO ACHIEVE A BETTER UNDERSTANDING OF CANCER BIOLOGY AND GUIDES THE DEVELOPMENT OF NEW TREATMENTS AND TREATMENT PROTOCOLS. CLINICAL TRIALS ARE COSTLY FOR HOSPITALS, WHICH RELY ON SUPPORT FROM CURESEARCH AND OTHER ORGANIZATIONS TO BE ABLE TO PROVIDE TREATMENT FOR CHILDREN WITH CANCER. EACH YEAR, ALMOST 10,000 CHILDREN ARE ENROLLED IN CLINICAL TRIALS. IN ADDITION TO FUNDING RESEARCH, CURESEARCH ALSO PROVIDES INFORMATION AND RESOURCES TO PATIENTS AND FAMILIES. CURESEARCH RESOURCES INCLUDE CURESEARCH.ORG, AN ONLINE RESOURCE WITH PLAIN LANGUAGE INFORMATION ON DIAGNOSIS AND TREATMENT FOR CHILDRENS CANCER; A LIBRARY OF PROCEDURE VIDEOS THAT DEMONSTRATE CANCER TREATMENTS FOR CHILDREN; AND WEBINARS AND GUIDES FOR PARENTS ON COPING WITH CANCER, FINDING COMMUNITY SUPPORT, AND REINTEGRATING A CHILD INTO SCHOOL AND SOCIAL ENVIRONMENTS. THESE RESOURCES AID ABOUT 28,500 INDIVIDUALS EACH YEAR. 4149437 1 1 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 0 0 0 1 1 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 15 0 1 43 1 0 0 0 0 0 0 0 0 X 15 15 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 AL AK AZ AR CA CO CT FL GA IL KS KY ME MD MA MI MN MS NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X X X MANAGEMENT 2402352200 4600 EAST WEST HIGHWAY BETHESDA MD 20814 STUART SIEGEL MD CHAIR 1.00 X X 0 0 0 MICHAEL MILLER ESQUIRE SECRETARY 1.00 X X 0 0 0 MICHAEL CARTER TREASURER 1.00 X X 0 0 0 LISA LIPSKY DIRECTOR 1.00 X X 0 0 0 ANNIE GOULD DIRECTOR 1.00 X 0 0 0 PAULA CARTER DIRECTOR 1.00 X 0 0 0 LAURA HOGAN MD DIRECTOR 1.00 X 0 0 0 MATT KELLY DIRECTOR 1.00 X 0 0 0 PRATHIMA ACHARYA PHD DIRECTOR 1.00 X 0 0 0 RICHARD J O'REILLEY MD DIRECTOR 1.00 X 0 0 0 CARLEEN HAWN DIRECTOR 1.00 X 0 0 0 HANK ADAMS DIRECTOR 1.00 X 0 0 0 ROBERT A BECK II DIRECTOR 1.00 X 0 0 0 WALTER B ROSE DIRECTOR 1.00 X 0 0 0 RAPHAEL ROUSSEAU MD PHD DIRECTOR 1.00 X 0 0 0 MARY PAYNE EMERITUS 1.00 X 0 0 0 RICHARD PAYNE EMERITUS 1.00 X 0 0 0 LAURA THRALL CEO/PRESIDENT 40.00 X 278674 0 22540 CHRISTINE BORK CHIEF DEVELOPMENT OFFICER 40.00 X 195212 0 11014 KATHARINE BURKE VP, FINANCE & OPERATIONS 40.00 X 156528 0 10290 SUSAN BRUMLEY VP OF INDIVIDUAL GIVING 40.00 X 160138 0 17319 790552 0 61163 4 0 1 0 0 2598912 102745 2598912 158815 158815 1905826 1833832 71994 71994 71994 2606761 152006 2454755 2454755 MISCELLANEOUS REVENUE 541700 3385 3385 3385 5287861 0 0 2688949 2477612 2477612 851715 347152 216124 288439 1682135 779645 180752 721738 35462 14418 3928 17116 188168 87122 26292 74754 178030 79305 27574 71151 57685 57685 69264 69264 27624 27624 135104 72660 17441 45003 91373 40702 14153 36518 197518 89496 32757 75265 228180 101645 35342 91193 143450 21117 7198 115135 64210 16716 14732 32762 30872 13752 4782 12338 BANK FEES 77671 3298 74373 OTHER PERSONNEL EXPENSE 11979 5333 1856 4790 LICENSES AND FEES 6199 2762 960 2477 6554251 4149437 741762 1663052 738819 155453 274187 281601 91000 108658 370956 376578 50880 90834 369674 285312 115234 84362 5466412 4760958 103040 172436 7210528 6030880 230422 259620 33638 35406 225334 265136 489394 560162 X 1280882 690493 2940252 2280225 2500000 2500000 6721134 5470718 7210528 6030880 -1266390 15974 0 X X 0 1 X 1 0 X 20951393 2291816 2132029 3341030 2598912 31315180 20951393 2291816 2132029 3341030 2598912 31315180 31315180 262928 152815 116282 173280 158815 864120 28847 4864593 4053583 3097244 2610146 14654413 46833713 0.66860 0.86490 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS - 2012 AMOUNT: $ 28,847. 2013 AMOUNT: $ 137,375. 2014 AMOUNT: $ 41,814. 2015 AMOUNT: $ 35. 2016 AMOUNT: $ 3,385. FUNDRAISING EVENTS - 2013 AMOUNT: $ 4,727,218. 2014 AMOUNT: $ 4,011,769. 2015 AMOUNT: $ 3,097,209. 2016 AMOUNT: $ 2,606,761. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 2969455 146915 146536 2969834 3095943 -25488 101000 2969455 2982976 165038 52071 3095943 2800368 300360 117752 2982976 2823269 96110 119011 2800368 0.84180 0.15820 0 0 171695 92289 79406 165329 165329 0 32650 27694 4956 84362 DEFERRED RENT 117502 DEFERRED COMPENSATION 147634 265136 X 5276211 15974 15974 5260237 27624 27624 5287861 6526627 0 6526627 27624 27624 6554251 PART V, LINE 4: DONOR RESTRICTED ENDOWMENT FUNDS HAVE BEEN ESTABLISHED TO ADVANCE PEDIATRIC CANCER RESEARCH BY DISEASE, BY MEDICAL DISCIPLINE, OR THROUGH RESEARCH FELLOWSHIPS. PART X, LINE 2: IN ACCORDANCE WITH FIN 48 (ASC 740), INCOME TAXES, MANAGEMENT EVALUATED ITS ACTIVITIES AND DETERMINED THAT CURESEARCH HAD TAKEN NO UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO OR DISCLOSURE IN THE FINANCIAL STATEMENTS TO COMPLY WITH THE PROVISIONS OF THE ACCOUNTING STANDARD. IN GENERAL, THE ORGANIZATION'S FEDERAL EXEMPT ORGANIZATION TAX RETURNS ARE SUBJECT TO EXAMINATION BY THE IRS, GENERALLY FOR A PERIOD OF THREE YEARS AFTER THE RETURNS ARE FILED. 1 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANT FOR CANCER RESEARCH GRANT FOR CANCER RESEARCH 486425 0 0 0 0 0 0 486425 0 486425 UNITED KINGDOM THERAPEUTIC 486425 WIRE TRANSFER 1 0 0 0 0 0 0 PART I, LINE 2: PROGRESS REPORTS ARE MONITORED WALK/RUN EVENT 2606761 2606761 21080 18725 16606 95595 2606761 2606761 21080 18725 16606 95595 152006 2454755 1 ANN & ROBERT H LURIE CHILDREN'S COLLEEN GARBE 225 E CHICAGO BOX 205 CHICAGO IL 60611 362170833 501 (C) (3) 10000 THERAPEUTIC CLEVELAND CLINIC FOUNDATION 9500 EUCLID AVENUE CLEVELAND OH 44195 340714585 501 (C) (3) 10000 THERAPEUTIC DANA FARBER CANCER INSTITUTE 450 BROOKLINE AVE BP412 BOSTON MA 022155450 422263040 501 (C) (3) 150000 THERAPEUTIC INOVA HEALTH CARE SERVICES 5580 PORT ROYAL ROAD SPRINGFIELD VA 22151 540620889 501 (C) (3) 10000 THERAPEUTIC LEHIGH VALLEY HOSPITAL - MUHLENBERG 2545 SCHOENERSVILLE ROAD 3RD FLOOR BETHLEHEM PA 18017 231689692 501 (C) (3) 10000 THERAPEUTIC METHODIST CHILDREN'S HOSPITAL 4000 24TH STREET LUBBOCK TX 79410 752428911 501 (C) (3) 9900 THERAPEUTIC MIAMI CHILDRENS HEALTH SYSTEM FOUNDATION INC 3100 SW 62ND AVE SUITE 121 NE WING MIAMI FL 33155 461784918 501 (C) (3) 10000 THERAPEUTIC NEMOURS CHILDREN'S CLINIC - JACKSONVILLE 807 CHILDRENS WAY JACKSONVILLE FL 32207 590634433 501 (C) (3) 10000 THERAPEUTIC NEW YORK UNIVERSITY SCHOOL OF MEDICINE 550 FIRST AVE NEW YORK NY 10016 135562308 501 (C) (3) 10000 THERAPEUTIC NEWARK BETH ISRAEL MEDICAL CENTER 201 LYONS AVE NEWARK NJ 07112 222587176 501 (C) (3) 9825 THERAPEUTIC OREGON HEALTH & SCIENCE UNIVERSITY 3181 SW SAM JACKSON PARK RD PORTLAND OR 97239 931176109 501 (C) (3) 9856 THERAPEUTIC ROCKY MOUNTAIN HOSPITAL FOR CHILDREN-PRESBYTERIAN ST LUKE'S 2055 HIGH ST SUITE 340 DENVER CO 80205 841321373 501 (C) (3) 10000 THERAPEUTIC SEATTLE CHILDREN'S HOSPITAL FOUNDATION PO BOX 24728 SEATTLE WA 98124 910564748 501 (C) (3) 75000 THERAPEUTIC STANFORD UNIVERSITY PO BOX 44253 SAN FRANCISCO CA 94144 941156365 501 (C) (3) 201243 THERAPEUTIC STONY BROOK FOUNDATION INC 230 ADMINISTRATION STONY BROOK UNIVERSITY STONY BROOK NY 11794 116077945 501 (C) (3) 10000 THERAPEUTIC TEDDY BEAR CANCER FOUNDATION 3892 STATE STREET SUITE 220 SANTA BARBARA CA 93105 141872081 501 (C) (3) 8500 THERAPEUTIC THE REGENTS OF THE UNIVERSITY OF CALIFORNIA- SAN FRAN 9500 GILMAN DRIVE MC 0009 LA JOLLA CA 92093 946036493 501 (C) (3) 613970 THERAPEUTIC UNIVERSITY OF PITTSBURGH 3100 CATHEDRAL OF LEARNING PITTSBURGH PA 15260 250965591 501 (C) (3) 75000 THERAPEUTIC UNIVERSITY OF UTAH HUNTSMAN CANCER INSTITUTE 201 SOUTH PRESIDENTS CIRCLE RM 40 SALT LAKE CITY UT 84112 SALT LAKE CITY UT 84112 876000525 501 (C) (3) 561085 THERAPEUTIC YALE UNIVERSITY PO BOX 1873 NEW HAVEN CT 06508 060646973 501 (C) (3) 75000 THERAPEUTIC 20 PART I, LINE 2: CURESEARCH'S MANAGEMENT WILL REQUEST PERIODIC REPORTS AND STATUS UPDATES OF ITS GRANT AWARDS THROUGHOUT THE YEAR. X X 0 1 0 0 0 0 0 0 0 LAURA THRALL CEO/PRESIDENT 278674 0 0 0 0 0 15423 0 7117 0 301214 0 0 0 CHRISTINE BORK CHIEF DEVELOPMENT OFFICER 195212 0 0 0 0 0 3947 0 7067 0 206226 0 0 0 KATHARINE BURKE VP, FINANCE & OPERATIONS 156528 0 0 0 0 0 3173 0 7117 0 166818 0 0 0 SUSAN BRUMLEY VP OF INDIVIDUAL GIVING 160138 0 0 0 0 0 3291 0 14028 0 177457 0 0 0 PART I, LINE 4B CURESEARCH ADOPTED A DEFERRED COMPENSATION PLAN UNDER INTERNAL REVENUE CODE 457(B) FOR THE BENEFIT OF CERTAIN KEY EMPLOYEES. UNDER THE PLAN, PARTICIPATING EMPLOYEES MAY ELECT TO DEFER A PORTION OF THEIR COMPENSATION ON A PRE-TAX BASIS INTO THE PLAN (UP TO PRESCRIBED LIMITS UNDER THE IRC). CURESEARCH MAY MAKE DISCRETIONARY CONTRIBUTIONS TO THE PLAN FOR EACH PARTICIPATING EMPLOYEE. CURESEARCH MADE CONTRIBUTIONS OF $10,123.00 TO THE PLAN DURING YEAR 2016 FOR THE BENEFIT OF LAURA THRALL, CEO/PRESIDENT. X 3 29420 FAIR MARKET VALUE X EVENT MANAGEMENT / PROMOTION SERVICES 1 73325 FAIR MARKET VALUE 0 0 1 PART I, LINE 32B: THE ORGANIZATION USES STOCK BROKERS TO SELL GIFTS OF PUBLICLY TRADED STOCK. FORM 990, PART VI, SECTION A, LINE 2 THE MEMBERSHIP OF CURESEARCH'S BOARD OF DIRECTORS INCLUDES MIKE AND PAULA CARTER (HUSBAND AND WIFE). FORM 990, PART VI, SECTION B, LINE 11B THE ORGANIZATION RETAINS AN OUTSIDE CPA TO PREPARE THE IRS FORM 990. PRIOR TO FILING, THE COMPLETED RETURN IS REVIEWED IN DETAIL BY THE CEO/PRESIDENT AND PRESENTED TO THE EXECUTIVE COMMITTEE OF THE BOARD. FORM 990, PART VI, SECTION B, LINE 12C EACH YEAR, ALL DIRECTORS, OFFICERS AND KEY EMPLOYEES ARE PROVIDED WITH THE CONFLICT OF INTEREST POLICY FOR REVIEW AND ARE REQUIRED TO SIGN AND SUBMIT THE ANNUAL CONFLICT OF INTEREST STATEMENT. FORM 990, PART VI, SECTION B, LINE 15A COMPENSATION OF THE CEO WAS DETERMINED BY THE BOARD CHAIR AFTER CONSIDERATION OF COMPATIBILITY DATA PROVIDED BY THE HUMAN RESOURCES DEPARTMENT. THE BOARD APPROVED THE BOARD CHAIR'S RECOMMENDATION. FORM 990, PART VI, SECTION C, LINE 19 CURESEARCH'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST. CURESEARCH'S FINANCIAL STATEMENTS AND FORM 990S ARE AVAILABLE ON ITS WEBSITE - CURESEARCH.ORG 990 PART VII, LINE 2C PROCESS HAS NOT CHANGED FROM PRIOR YEAR